Back to video list Back to Home Which patients should receive a monoclonal antibody for migraine prevention and the implications of medication overuse You may also like Schizophrenia Article Improving cognition and motivation in schizophrenia to address patient’s goal of restoring social functioning Depression Article One size does not fit all…or does it?: Heterogeneity within depression Mental Health Congress highlights Article The pandemic has permanently changed psychiatry, but perhaps not radically Schizophrenia Article Glutamate and Oxidative Stress: A novel approach to pathophysiology in schizophrenia